Blue Jet Healthcare financials

·Pharma & HealthChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹293cr−17.4% on Q1 FY26
Net profit
₹78.3cr−14.2% on Q1 FY26
EBITDA margin
33.5%−0.6 pts on Q1 FY26
EPS
₹4.51−14.3% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue293355−17.4%
EBITDA98.1121−18.9%
EBITDA margin33.5%34.1%−0.6 pts
Profit before tax106123−13.8%
Net profit78.391.2−14.2%
EPS₹4.51₹5.26−14.3%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹293 crNet profit₹78.3 crNet margin26.7%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY25Mar 2025FY24Mar 2024
220220276
886——
271——
30.6%——
246——
235——
26.5%——
—45.8241
—−79.9−173
−34.1−34.168.4
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BLUEJET₹517.85

Blue Jet Healthcare Ltd.

· Pharma & Health
₹ CrorePeersDIVISLABAARTIPHARMCAPLIPOINTACUTAASCONCORDBIOEMCUREERISGRANULES
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
Current/LTM
TTM · last close
- Cash, Equiv & ST Investments276.4219.7219.7
Revenue——885.7
EBITDA——271.2
Margin %——30.62
EBIT——246.2
Net Income——234.9
Margin %——26.52
Cash from Operations241.345.8—
Capital Expenditures-172.9-79.9—
Free Cash Flow68.4-34.1-34.1
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 97%.

Blue Jet Healthcare financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Blue Jet Healthcare (NSE: BLUEJET) had a market capitalisation of ₹8,735 crore at the 29 October 2026 close (₹503.55 a share), a PE ratio of 37.2 on the last four quarters' profit and a price-to-book ratio of 6.42. It had no borrowings on 31 March 2026. Promoters held 73.15% of the shares on 30 September 2026.

Share price used
₹503.55 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Blue Jet Healthcare at a glance · consolidated

Market cap
₹8,735 Crat ₹503.55 · 29 Oct close
PE ratio (last 4 quarters)
37.2
Price to book (PB)
6.42book value ₹78.40 a share
Debt to equity
0.00net cash ₹376 Cr
Promoter holding
73.15%−6.7 pts vs 30 Jun 202630 September 2026
Dividend yield
0.24%₹1.20 a share in 12 months

Questions

What is the Blue Jet Healthcare PE ratio today?

Blue Jet Healthcare's PE ratio is 37.2 at the 29 October 2026 close (₹503.55 a share): a market capitalisation of ₹8,735 crore divided by consolidated net profit of ₹235 crore over the last four quarters (Q2 FY26 to Q1 FY27).

What is the Blue Jet Healthcare net worth?

Blue Jet Healthcare's net worth — shareholders' equity in its consolidated balance sheet — was ₹1,360 crore on 31 March 2026, up 20.0% from ₹1,133 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹8,735 crore at the 29 October 2026 close.

What is the Blue Jet Healthcare book value per share?

Blue Jet Healthcare's book value per share was ₹78.40 on 31 March 2026: shareholders' equity of ₹1,360 crore divided by the 17.35 crore shares in issue, up 20.0% from ₹65.32 a year earlier. The share price at the 29 October 2026 close was ₹503.55.

What is the Blue Jet Healthcare PB ratio (price to book value)?

Blue Jet Healthcare's price-to-book (PB) ratio is 6.42 at the 29 October 2026 close: a market capitalisation of ₹8,735 crore divided by shareholders' equity (book value) of ₹1,360 crore on 31 March 2026. That is a book value of ₹78.40 per share against a share price of ₹503.55.

What is the Blue Jet Healthcare dividend yield?

Blue Jet Healthcare's dividend yield is 0.24% at the 29 October 2026 close: dividends of ₹1.20 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹503.55. They were ₹1.20 on 11 September 2026.

What is the Blue Jet Healthcare promoter holding?

Promoters held 73.15% of Blue Jet Healthcare on 30 September 2026, down 6.66 percentage points from 79.81% the previous quarter and down 6.66 percentage points from 79.81% a year earlier, according to the shareholding pattern filed with NSE.

What is the Blue Jet Healthcare market cap?

Blue Jet Healthcare's market capitalisation was ₹8,735 crore at the 29 October 2026 close: 17.35 crore shares at ₹503.55 each.

Is Blue Jet Healthcare debt free?

Yes. Blue Jet Healthcare had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹376 crore of cash, bank balances and current investments.

What is the Blue Jet Healthcare dividend in 2026 and its record date?

In 2026, Blue Jet Healthcare has declared one dividend: ₹1.20 with record date 14 September 2026 and ex-date 11 September 2026.

What is the Blue Jet Healthcare debt to equity ratio?

Blue Jet Healthcare's debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹1,360 crore. A year earlier, on 31 March 2025, it was 0.00.

What is the Blue Jet Healthcare free cash flow?

In FY25, Blue Jet Healthcare generated ₹45.8 crore of cash from operations and spent ₹79.9 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹34.1 crore. In FY24 it was ₹68.4 crore.

What are the Blue Jet Healthcare latest quarterly results?

Blue Jet Healthcare's latest results are for Q1 FY27 (April–June 2026), filed on 3 August 2026: consolidated net profit ₹78.3 crore, down 14.2% from ₹91.2 crore in Q1 FY26; revenue from operations ₹293 crore, down 17.4% year on year.

What is the Blue Jet Healthcare shareholding pattern?

On 30 September 2026, Blue Jet Healthcare's shares were held by promoters 73.15%, foreign portfolio investors (FII/FPI) 0.82%, domestic institutions (DII) 7.49% (including mutual funds at 4.10%) and retail and other non-institutional investors 18.55%. Over the year, FII holding was down 1.00 percentage points from 1.82% and DII holding was up 3.86 percentage points from 3.63%.

When are the Blue Jet Healthcare next results?

Blue Jet Healthcare will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, the date of the board meeting it has notified to the exchanges.

Where do these Blue Jet Healthcare figures come from?

From Blue Jet Healthcare's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.